Quest PharmaTech Competitors and Similar CompaniesClear all

Quest PharmaTech's competitors and similar companies include Alligator Bioscience, Xilio Therapeutics, OncoArendi Therapeutics and Karo Healthcare.

	Quest PharmaTech Quest PharmaTech is a pharmaceutical company that develops drugs with a focus on the treatment of cancer.	Alligator Bioscience Alligator develops antibody-based pharmaceuticals for cancer treatment.	Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.	OncoArendi Therapeutics OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates.	Karo Healthcare Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
Founding Date	Founding Date N/A	Founding Date 2001	Founding Date 2015	Founding Date 2012	Founding Date 1987
Type	Type Public	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations Edmonton, CA HQ	Locations Lund, SE HQ	Locations Waltham, US HQ	Locations Warszawa, PL HQ Łódź, PL	Locations Stockholm, SE HQ Stockholm, SE
Employees	Employees N/A	Employees 1555% decrease	Employees 69	Employees 839% increase	Employees 225
Valuation ($)	Valuation ($) 3 m	Valuation ($) 59 m	Valuation ($) 43.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) kr514k (FY, 2025)	Revenue (est.) $43.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) kr3b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods kr1.3b (FY, 2021)
Gross profit	Gross profit N/A	Gross profit kr1.1m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit kr1.7b (FY, 2021)
Net income	Net income ($1.8m) (FY, 2025)	Net income (kr51.4m) (FY, 2025)	Net income ($35m) (FY, 2025)	Net income N/A	Net income (kr17m) (FY, 2021)